Entry Detail



General Information

Database ID:exR0000029
RNA Name:ABCA2
RNA Type:mRNA
Chromosome:chr9
Starnd:-
Coordinate:
Start Site(bp):137007234End Site(bp):137028922
External Links:ENSG00000107331



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
STK11
chr19
1177558
1228431
+
SLC36A4
chr11
93144174
93197991
-
KBTBD11
chr8
1973677
2006936
+
BMP2K
chr4
78776342
78916372
+
EXOC7
chr17
76081016
76121576
-
SMG5
chr1
156249224
156282825
-
SPECC1L
chr22
24270817
24417739
+
XXYLT1
chr3
195068284
195271159
-
NIP7
chr16
69337996
69343106
+
MYL5
chr4
673580
682033
+
RBPJ
chr4
26163455
26435131
+
REEP5
chr5
112876385
112922289
-
GANAB
chr11
62624826
62646726
-
DDX6
chr11
118747763
118791164
-
METTL26
chr16
634427
636366
-
ACAP3
chr1
1292390
1309609
-
LRP5
chr11
68312591
68449275
+
SUPT5H
chr19
39436156
39476670
+
MCM2
chr3
127598410
127622436
+
HNRNPK
chr9
83968083
83980616
-
FLNA
chrX
154348524
154374638
-
SRRM2
chr16
2752626
2772538
+
POMGNT1
chr1
46188682
46220305
-
PLXNA1
chr3
126988594
127037392
+
HDGFL3
chr15
83112738
83207823
-
YWHAQ
chr2
9583967
9630997
-
LMAN2
chr5
177331567
177351668
-
HECA
chr6
139135080
139180802
+
SEC24C
chr10
73744372
73772161
+
EXTL3
chr8
28600469
28755599
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-1286
chr22
20249145
20249165
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AC067930.1
chr8
143579636
143580670
+
AD000090.1
chr19
35557956
35581954
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.